Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-088031
Filing Date
2023-03-31
Accepted
2023-03-31 16:09:52
Documents
7
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A d425141dpre14a.htm PRE 14A 543425
2 GRAPHIC g425141g01a01.jpg GRAPHIC 37467
3 GRAPHIC g425141g06a06.jpg GRAPHIC 55920
4 GRAPHIC g425141g13j07.jpg GRAPHIC 17377
5 GRAPHIC g425141g51w01.jpg GRAPHIC 53138
6 GRAPHIC g425141g73l41.jpg GRAPHIC 60831
7 GRAPHIC g425141g90t91.jpg GRAPHIC 23079
  Complete submission text file 0001193125-23-088031.txt   886725
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39659 | Film No.: 23787681
SIC: 8071 Services-Medical Laboratories